<DOC>
	<DOC>NCT01077024</DOC>
	<brief_summary>The primary objective of this study is to evaluate the impact of substance-abuse treatment as usual plus smoking-cessation treatment (TAU+SCT), relative to substance-abuse treatment as usual (TAU), on drug-abuse outcomes. Specifically, this study will evaluate whether concurrent smoking-cessation treatment improves, worsens, or has no effect on stimulant-use outcomes in smokers who are in outpatient substance-abuse treatment for cocaine or methamphetamine dependence.</brief_summary>
	<brief_title>Smoking-Cessation and Stimulant Treatment (S-CAST)</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Clinical diagnosis of cocaine/methamphetamine dependence Smoked cigarettes for at least 3 months Currently smoking &gt; 6 cigarettes/day Have an interest in quitting smoking Enrolled in outpatient treatment at a participating site Clinical diagnosis of current alcohol or sedative dependence, bipolar disorder; or a lifetime diagnosis of anorexia nervosa or bulimia Seeking/receiving treatment for opiateagonist replacement therapy Medical conditions that could compromise participant safety Taking medications with known/potential interactions with bupropion Hypersensitivity to bupropion, nicotine, or menthol Pregnant or breastfeeding Abnormal ECG Recent smoking cessation treatment Use of tobacco products other than cigarettes in the past week Likely to enter residential/inpatient treatment within 10 weeks Have all stimulantpositive urine drug screens during screening/baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Stimulant treatment</keyword>
	<keyword>Smoking Cessation</keyword>
</DOC>